Showing 1,286 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

The search for a cure

Latest data on HIV cure research

News
27 July 2012
New & experimental HIV treatments

Dolutegravir matches raltegravir for people starting treatment

News
27 July 2012
New & experimental HIV treatments

Pioneering study shows drug can purge dormant HIV

Editor's pick
Science Daily
25 July 2012
Vaginal rings & topical PrEP

Researchers to test monthly vaginal ring for HIV prevention

Editor's pick
Reuters
25 July 2012
New & experimental HIV treatments

Once-daily maraviroc plus boosted atazanavir promising at 96 weeks

News
25 July 2012
New & experimental HIV treatments

Similar Efficacy, Side Effects in Study of Gilead Booster Cobicistat and Norvir

Editor's pick
AIDSMeds
25 July 2012
HIV treatment for children & young people

Adolescent antiretroviral options expanding

News
25 July 2012
HIV treatment for children & young people

New antiretrovirals for infants and children still needed

News
25 July 2012
New & experimental HIV treatments

Merck Signs Two Deals for Novel HIV Drug Candidates and Initiates Phase II Clinical Trial of MK-1439 for HIV

Editor's pick
Merck press release
24 July 2012
New & experimental HIV treatments

TAG/i-base 2012 Pipeline Report - HIV/HCV/TB

Editor's pick
Treatment Action Group
21 July 2012
New & experimental HIV treatments

HIV drug reduces graft-vs.-host disease in bone marrow transplant patients

Editor's pick
Google Alerts HIV
12 July 2012
New & experimental HIV treatments

Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV

Editor's pick
Market Watch (press release)
11 July 2012
New & experimental HIV treatments

HIV quad pill 'may improve care'

Editor's pick
BBB News
29 June 2012
New & experimental HIV treatments

Gilead Sciences files for approval of cobicistat

Editor's pick
Bloomberg BusinessWeek
29 June 2012
The search for a cure

Four-class, five-drug regimen given to monkeys shows signs of producing long-term viral load reductions off treatment

News
29 June 2012
PrEP science

The road to PrEP: trials, regulation and roll-out

News
25 June 2012
Weight gain & lipodystrophy

Theratechnologies sinks on HIV drug setback

Editor's pick
Reuters
22 June 2012
New & experimental HIV treatments

European Medicines Agency Validates Gilead ’s Marketing Application for Elvitegravir for Treatment of HIV Infection

Editor's pick
Gilead press release
19 June 2012
New & experimental HIV treatments

New Drug-Screening Method Yields Long-Sought Anti-HIV Compounds

Editor's pick
Scripps Research Institute
15 June 2012
Undetectable viral load & treatment as prevention

Study shows that use of darunavir/ritonavir and etravirine in HIV treatment as a prevention method is biologically plausible

News
13 June 2012
New & experimental HIV treatments

UBC drug formulation receives $1.1 million for clinical development as HIV treatment

Editor's pick
EurekAlert (press release)
6 June 2012
New & experimental HIV treatments

Gilead Files European Marketing Application for Boosting Agent Cobicistat

Editor's pick
Gilead press release
25 May 2012
Drug interactions & pharmacokinetics

13th International workshop on Clinical Pharmacology of HIV Therapy 16–18 April 2012, Barcelona

Editor's pick
i-base
23 May 2012
New & experimental HIV treatments

Broad-Spectrum Antivirals: The Future of HIV Treatment?

Editor's pick
The Body
17 May 2012